These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3946663)

  • 1. Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol.
    Moleman P; Janzen G; von Bargen BA; Kappers EJ; Pepplinkhuizen L; Schmitz PI
    Am J Psychiatry; 1986 Feb; 143(2):232-4. PubMed ID: 3946663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of bromperidol versus haloperidol in psychotic patients.
    Denijs EL
    Int Pharmacopsychiatry; 1980; 15(5):309-17. PubMed ID: 7021451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate.
    Matthew BJ; Gedzior JS
    Int J Psychiatry Med; 2015; 50(4):405-11. PubMed ID: 26526398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual contrast sensitivity in drug-induced Parkinsonism.
    Bulens C; Meerwaldt JD; van der Wildt GJ; Keemink CJ
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):341-5. PubMed ID: 2926418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom.
    Bateman DN; Rawlins MD; Simpson JM
    Q J Med; 1986 Jun; 59(230):549-56. PubMed ID: 3749448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haloperidol in the treatment of psychotic disorders in old age].
    Kobrzyńska E; Chachaj L
    Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
    [No Abstract]   [Full Text] [Related]  

  • 9. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism by haloperidol and piribedil.
    Corsini GU; Del Zompo M; Spissu A; Mangoni A; Gessa GL
    Psychopharmacology (Berl); 1978 Oct; 59(2):139-41. PubMed ID: 103114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of haloperidol in chronic psychotic patients.
    Lapolla A
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications.
    Zbytovský J; Zapletálek M
    Act Nerv Super (Praha); 1989 Dec; 31(4):266-7. PubMed ID: 2638106
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent drug-induced parkinsonism.
    Aronson TA
    Biol Psychiatry; 1985 Jul; 20(7):795-8. PubMed ID: 4005336
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
    Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of injectable haloperidol and chlorpromazine.
    Ritter RM; Davidson DE; Robinson TA
    Am J Psychiatry; 1972 Jul; 129(1):78-81. PubMed ID: 4556089
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient.
    Carter RG
    Dis Nerv Syst; 1977 Apr; 38(4):237-9. PubMed ID: 849701
    [No Abstract]   [Full Text] [Related]  

  • 19. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.